Fucoidan Ameliorates Hepatocellular Carcinoma Induced in Rats: Effect on miR143 and Inflammation

References

• Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017; 24(3):1073274817729245. doi:10.1177/1073274817729245
   Web of Science ®Google Scholar
• Zhan T, Sollors J, Steinebrunner N, Schlitt HJ, Stroszczynski C, Weiss KH, Ebert MP, Teufel A. Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus - Case series and literature review. Z Gastroenterol. 2019;57(4):501–507. doi:10.1055/a-0855-4469
   PubMed Web of Science ®Google Scholar
• Al-Gayyar MMH, Bagalagel A, Noor AO, Almasri DM, Diri R. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Biomed Pharmacother. 2019;112:108653. doi:10.1016/j.biopha.2019.108653
   PubMed Web of Science ®Google Scholar
• Su Z-X, Zhao J, Rong Z-H, Geng W-M, Wu Y-G, Qin C-K. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagn Pathol. 2014;9(1):47. doi:10.1186/1746-1596-9-47
   PubMed Web of Science ®Google Scholar
• Trakooljul N, Hicks JA, Liu HC. Identification of target genes and pathways associated with chicken microRNA miR-143. Anim Genet. 2010;41(4):357–364. doi:10.1111/j.1365-2052.2009.02015.x
   PubMed Web of Science ®Google Scholar
• Zhang Z-q, Meng H, Wang N, Liang L-n, Liu L-n, Lu S-m, Luan Y. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma. Diagn Pathol. 2014;9(1):135. doi:10.1186/1746-1596-9-135
   PubMed Web of Science ®Google Scholar
• Wu L, Sun J, Su X, Yu Q, Yu Q, Zhang P. A review about the development of fucoidan in antitumor activity: Progress and challenges. Carbohydr Polym. 2016;154:96–111. doi:10.1016/j.carbpol.2016.08.005
   PubMed Web of Science ®Google Scholar
• Deepika MS, Thangam R, Sheena TS, Sasirekha R, Sivasubramanian S, Babu MD, Jeganathan K, Thirumurugan R. A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomed Pharmacother. 2019;109:1181–1195. doi:10.1016/j.biopha.2018.10.178
   PubMed Web of Science ®Google Scholar
• Collins K, Fitzgerald G, Stanton C, Ross R. Looking beyond the terrestrial: The potential of seaweed derived bioactives to treat non-communicable diseases. Mar Drugs 2016; 14(3):60. doi:10.3390/md14030060
   PubMed Web of Science ®Google Scholar
• Amin ML, Mawad D, Dokos S, Koshy P, Martens PJ, Sorrell CC. Immunomodulatory properties of photopolymerizable fucoidan and carrageenans. Carbohydr Polym. 2020; 230:115691. doi:10.1016/j.carbpol.2019.115691
   PubMed Web of Science ®Google Scholar
• Lin Y, Qi X, Liu H, Xue K, Xu S, Tian Z. The anti-cancer effects of fucoidan: A review of both in vivo and in vitro investigations. Cancer Cell Int. 2020;20:154. doi:10.1186/s12935-020-01233-8
   PubMed Web of Science ®Google Scholar
• Cho Y, Yoon J-H, Yoo J-J, Lee M, Lee DH, Cho EJ, Lee J-H, Yu SJ, Kim YJ, Kim CY, et al. Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharm Sin B. 2015;5(6):544–553. doi:10.1016/j.apsb.2015.09.004
   PubMed Web of Science ®Google Scholar
• Yan M-D, Yao C-J, Chow J-M, Chang C-L, Hwang P-A, Chuang S-E, Whang-Peng J, Lai G-M. Fucoidan elevates microRNA-29b to regulate DNMT3B-MTSS1 axis and inhibit EMT in human hepatocellular carcinoma cells. Mar Drugs 2015;13(10):6099–6116. doi:10.3390/md13106099
   PubMed Web of Science ®Google Scholar
• Yang L, Wang P, Wang H, Li Q, Teng H, Liu Z, Yang W, Hou L, Zou X. Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar Drugs 2013;11(6):1961–1976. doi:10.3390/md11061961
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kawaguchi M, Kitamura K, Narumiya S, Kawamura M, Tengan I, Nishimoto S, Hanamure Y, Majima Y, Tsubura S, et al. An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients. Integr Cancer Ther. 2018;17(2):282–291. Jundoi:10.1177/1534735417692097
   PubMed Web of Science ®Google Scholar
• Al-Gayyar MM, Abbas A, Hamdan AM. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma. Biol Chem. 2016;397(3):257–267. doi:10.1515/hsz-2015-0265
   PubMed Web of Science ®Google Scholar
• Nazmy EA, El-Khouly OA, Zaki MMA, Elsherbiny NM, Said E, Al-Gayyar MMH, Salem HA. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats. Environ Toxicol Pharmacol. 2019;72:103240. doi:10.1016/j.etap.2019.103240
   PubMed Web of Science ®Google Scholar
• Sherif IO, Al-Gayyar M. Oleuropein potentiates anti-tumor activity of cisplatin against HepG2 through affecting proNGF/NGF balance. Life Sci. 2018;198:87–93. doi:10.1016/j.lfs.2018.02.027
   PubMed Web of Science ®Google Scholar
• Angelidakis G, Krishnan S, Cabrera NL, Jiang Y, Pushparaji B, Kaseb A, Torres HA. Virologic impact of radiotherapy in hepatitis C virus-infected patients with hepatocellular carcinoma. Hepatology 2020. doi:10.1002/hep.31114
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009;50(2):490–499. doi:10.1002/hep.23008
   PubMed Web of Science ®Google Scholar
• Bae H, Lee J-Y, Yang C, Song G, Lim W. Fucoidan derived from Fucus vesiculosus inhibits the development of human ovarian cancer via the disturbance of calcium homeostasis, endoplasmic reticulum stress, and angiogenesis. Mar Drugs 2020;18(1):45. doi:10.3390/md18010045
   PubMed Web of Science ®Google Scholar
• Van Weelden G, Bobiński M, Okła K, Van Weelden WJ, Romano A, Pijnenborg JMA. Fucoidan structure and activity in relation to anti-cancer mechanisms. Mar Drugs 2019;17(1):32. doi:10.3390/md17010032
   PubMed Web of Science ®Google Scholar
• Duan Y, Li J, Jing X, Ding X, Yu Y, Zhao Q. Fucoidan induces apoptosis and inhibits proliferation of hepatocellular carcinoma via the p38 MAPK/ERK and PI3K/Akt signal pathways. Cancer Manag Res. 2020;12:1713–1723. doi:10.2147/CMAR.S243495
   PubMed Web of Science ®Google Scholar
• Shi W, Hu J, Zhu S, et al. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis. Int J Clin Exp Pathol. 2015;8(10):13083–13089.
   PubMed Web of Science ®Google Scholar
• Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma. J Gastrointestin Liver Dis. 2008;17(4):411–477.
   PubMed Web of Science ®Google Scholar
• Alyoussef A, Al-Gayyar M. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother. 2018;103:362–372. doi:10.1016/j.biopha.2018.04.060
   PubMed Web of Science ®Google Scholar
• Hamdan AM, Al-Gayyar MM, Shams MEE, Alshaman US, Prabahar K, Bagalagel A, Diri R, Noor AO, Almasri D. Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives. Sci Rep. 2019;9(1):7026. doi:10.1038/s41598-019-43568-x
   PubMed Web of Science ®Google Scholar
• Wang Y-Q, Wei J-G, Tu M-J, Gu J-G, Zhang W. Fucoidan alleviates acetaminophen-induced hepatotoxicity via oxidative stress inhibition and Nrf2 translocation. IJMS. 2018;19(12):4050. doi:10.3390/ijms19124050
   Web of Science ®Google Scholar
• Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. Int J Biol Macromol. 2018;112:929–236. doi:10.1016/j.ijbiomac.2018.02.072
   PubMed Web of Science ®Google Scholar
• Abdel-Daim MM, Abushouk AI, Bahbah EI, Bungău SG, Alyousif MS, Aleya L, Alkahtani S. Fucoidan protects against subacute diazinon-induced oxidative damage in cardiac, hepatic, and renal tissues. Environ Sci Pollut Res. 2020;27(11):11554–11564. doi:10.1007/s11356-020-07711-w
   PubMed Web of Science ®Google Scholar
• AlKahtane AA, Abushouk AI, Mohammed ET, ALNasser M, Alarifi S, Ali D, Alessia MS, Almeer RS, AlBasher G, Alkahtani S, et al. Fucoidan alleviates microcystin-LR-induced hepatic, renal, and cardiac oxidative stress and inflammatory injuries in mice. Environ Sci Pollut Res. 2020;27(3):2935–2944. doi:10.1007/s11356-019-06931-z
   PubMed Web of Science ®Google Scholar
• Meenakshi S, Umayaparvathi S, Saravanan R, Manivasagam T, Balasubramanian T. Hepatoprotective effect of fucoidan isolated from the seaweed Turbinaria decurrens in ethanol intoxicated rats. Int J Biol Macromol. 2014;67:367–372. doi:10.1016/j.ijbiomac.2014.03.042
   PubMed Web of Science ®Google Scholar
• Mamdouh S, Khorshed F, Aboushousha T, Hamdy H, Diab A, Seleem M, Saber M. Evaluation of Mir-224, Mir-215 and Mir-143 as serum biomarkers for HCV associated hepatocellular carcinoma. Asian Pac J Cancer Prev. 2017;18(11):3167–3171. doi:10.22034/APJCP.2017.18.11.3167
   PubMedGoogle Scholar
• Xue F, Yin J, Xu L, Wang B. MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6. Exp Ther Med. 2017; 13(6):2667–2674. doi:10.3892/etm.2017.4348
   PubMed Web of Science ®Google Scholar
• Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9(6):7204–7218. doi:10.18632/oncotarget.23208
   PubMedGoogle Scholar
• El Awdan SA, Amin MM, Hassan A. Cilostazol attenuates indices of liver damage induced by thioacetamide in albino rats through regulating inflammatory cytokines and apoptotic biomarkers. Eur J Pharmacol. 2018; 822:168–176. doi:10.1016/j.ejphar.2018.01.021
   PubMed Web of Science ®Google Scholar
• Jekarl DW, Lee S, Kwon JH, Nam SW, Kim M, Kim Y, Jang JW. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma. PLoS One 2019;14(11):e0224318. doi:10.1371/journal.pone.0224318
   PubMed Web of Science ®Google Scholar
• Do H, Pyo S, Sohn EH. Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells. J Nutr Biochem. 2010;21(8):671–679. doi:10.1016/j.jnutbio.2009.03.013
   PubMed Web of Science ®Google Scholar